美国当代TAVR与MTEER术者手术量与结局的关联
调整分析显示,低容量TAVR术者(<15例/年)较高容量术者(>37例/年)30天死亡风险更高(OR 1.13),低容量MTEER术者(<8例/年)较高容量术者(>16例/年)院内并发症风险更高(OR 1.31)。
要点
- 低容量TAVR术者(<15例/年)较高容量术者(>37例/年)30天死亡风险升高(OR 1.13)。
- 低容量MTEER术者(<8例/年)较高容量术者(>16例/年)院内并发症风险升高(OR 1.31)。
- 术者容量与结局的关联在各医院容量分层中一致,且TAVR与MTEER术者结局不相关。
核心结论
- 当代美国注册数据显示,TAVR和MTEER的术者手术量与患者结局之间持续存在负相关。
研究设计与样本
- cohort 研究,分析STS/ACC TVT注册库中2020年1月至2023年12月接受TAVR或MTEER的连续患者。
- 采用两水平随机效应logistic回归模型评估术者手术量与30天结局的关联。
主要发现
- TAVR患者中位年龄79.0岁(IQR 73.0–85.0),女性占42.4%;MTEER患者中位年龄79.0岁(IQR 71.0–84.0),女性占45.5%。
关键数值与推荐
- TAVR低容量术者定义为年手术量<15例,高容量术者定义为>37例/年。
- MTEER低容量术者定义为年手术量<8例,高容量术者定义为>16例/年。
- 低容量术者的过程照护指标较高容量术者更差。
临床怎么用
- 在选择TAVR或MTEER术者时,可参考术者年手术量以优化患者结局。
- 未来政策制定可考虑术者手术量阈值以保障手术质量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Recent evidence suggests that hospital-level associations between procedural volume and outcomes for transcatheter aortic valve replacement (TAVR) and mitral transcatheter edge-to-edge repair (MTEER) may be plateauing. Less is known about the operator volumes-outcomes association in the contemporary era. OBJECTIVE: To determine whether an operator-level volume-outcomes association exists for TAVR and MTEER in the contemporary era. DESIGN, SETTING, AND PARTICIPANTS: This cohort study examined data from patients undergoing TAVR or MTEER between January 2020 and December 2023 included in the Society of Thoracic Surgeons (STS)/American College of Cardiology (ACC) Transcatheter Valve Therapies (TVT) Registry, a national all-comers real-world registry. Consecutive patients undergoing TAVR for aortic stenosis or MTEER for mitral regurgitation were included. Data analysis was performed from October 2024 to December 2025. EXPOSURE: TAVR or MTEER. MAIN OUTCOMES AND MEASURES: The primary outcome measures were (1) 30-day all-cause mortality, (2) a 30-day composite outcome, and (3) in-hospital procedural complications following TAVR or MTEER. Data from the STS/ACC TVT Registry were analyzed for patients undergoing TAVR or MTEER between 2020 and 2023. The primary analysis assessed the association between operator volume and 30-day outcomes using a 2-level random-effects logistic regression model. The interaction between operator and hospital volumes and the association between TAVR and MTEER outcomes were also evaluated. RESULTS: A total of 358 943 patients underwent TAVR at 827 hospitals (7524 operators; median [IQR] annual volume, 24 [11-47]), and 51 407 patients underwent MTEER at 493 hospitals (2483 operators; median [IQR] annual volume, 12 [7-19]). For TAVR, median (IQR) patient age was 79.0 (73.0-85.0) years, and 152 186 patients (42.4%) were female; for MTEER, median (IQR) patient age was 79.0 (71.0-84.0) years, and 23 402 patients (45.5%) were female. Low-volume operators demonstrated inferior process of care measures compared with high-volume operators. In adjusted analyses, a higher risk of 30-day mortality (odds ratio [OR], 1.13; 95% CI, 1.02-1.26; P = .02) and in-hospital complications (OR, 1.09; 95% CI, 1.03-1.16; P = .005) was observed for low-volume TAVR operators (<15/y) compared with high-volume operators (>37/y). For MTEER, in-hospital complications (OR, 1.31; 95% CI, 1.11-1.56; P = .002) were higher for low-volume operators (<8/y) compared with high-volume operators (>16/y), while 30-day mortality was not different (OR, 1.16; 95% CI, 0.96-1.41; P = .12). Associations were consistent across hospital volume strata. Operator-level outcomes for TAVR and MTEER were not correlated. CONCLUSIONS AND RELEVANCE: In this cohort study, results from a large, contemporary US registry demonstrate a persistent inverse association between operator volume and patient outcomes for both TAVR and MTEER. These findings may help inform future policies aimed at ensuring optimal outcomes.
引用
- Kumbhani DJ, Girotra S, Dong H, et al. Contemporary Operator Procedural Volumes and Outcomes for TAVR and MTEER in the US. JAMA Cardiol. 2026. PMID: 41505119. doi:10.1001/jamacardio.2025.5645
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。